“Prevention is better than cure” is the mantra spurring some of this year’s 30 Under 30 Asia listees in the Healthcare & Science category to start their health-tech ventures. Stroke is the world’s second-leading cause of death after heart disease, a statistic that inspired Milad Mohammadzadeh and Sadaf Monajemi in 2017 to launch See-Mode Technologies to better predict the risk of strokes.
Tech in Asia reported that Singapore-based healthtech startup Lucence has raised US$20 million in a series A round led by global healthcare provider IHH Healthcare, with participation from SGInnovate and Heliconia Capital, amongst others. Lucence, which is a spinoff from A*Star in 2016, uses liquid biopsy, a blood-based technology that’s less invasive than tissue biopsies, to help clinicians analyse a tumour and make treatment decisions. The new funds will enable the company to reach more patients across Asia and North America, and the company is planning to embark on new prospective clinical studies to evaluate its technology for early detection of multiple cancers.
Through various industrial revolutions, societies have adapted and molded the environment that we live in for our betterment. Artificial intelligence (AI) should be seen as complementing human skillsets, rather than being a threat.
The Straits Times Online reported on SGInnovate's investment in MediLOT Technologies for an undisclosed amount as part of its strategy to develop research-based deep tech start-ups. Based in Singapore, MediLOT Technologies is built on blockchain, AI and database management system technologies for patients, healthcare practitioners, and oganisations, giving them access to private and secure health data for better diagnoses and effective treatments. MediLOT is the first Blockchain and Healthcare Analytics company in Singapore that SGInnovate has invested in, which is in line with its mission to help develop high potential companies with products that will have global impact.
GovTech published an article on SGInnovate’s Health Futures: AI & Genomics seminar, where a panel of experts discussed how AI is working alongside doctors and researchers to uncover the secrets of the human genome. Thousands of genomes have already been sequenced, representing a treasure trove of data – one that leaves clinicians overwhelmed by the sheer volume of information it holds. The promise of AI is to help doctors mine the medical literature and pick out actionable insights more quickly and easily.